(Q54063836)

24 May 2018

title

Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95. (English)

1 reference

24 May 2018

author name string

Re D

1 reference

24 May 2018

Hofmann A

1 reference

24 May 2018

Wolf J

1 reference

24 May 2018

Diehl V

1 reference

24 May 2018

Staratschek-Jox A

1 reference

24 May 2018

publication date

1 January 2000

1 reference

24 May 2018

published in

Experimental Hematology

1 reference

24 May 2018

volume

1 reference

24 May 2018

issue

1 reference

24 May 2018

page(s)

31-35

1 reference

24 May 2018

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Fas expression and apoptosis in human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Establishment of a malignant, epstein-barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Death of solid tumor cells induced by Fas ligand expressing primary myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

1 reference

7 January 2021

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

The mummified Hodgkin cell: cell death in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900125-3

7 January 2021

10.1016/S0301-472X(99)00125-3

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018